期刊文献+

耐碳青霉烯类鲍氏不动杆菌感染医院内流行现状与预防控制 被引量:4

Current status of epidemiology of carbapenems-resistant Acinetobacter baumannii infections and effectiveness of infection control
原文传递
导出
摘要 目的了解耐碳青霉烯类鲍氏不动杆菌(CR-ABA)感染医院内流行现状,探讨CR-ABA医院感染预防控制措施。方法前瞻性调查2011年1月-2012年12月住院患者感染鲍氏不动杆菌(ABA)情况,判断其感染类型及分析CR-ABA感染特征,采取感染预防控制措施,并观察其效果。结果共调查ABA感染患者258例次,其中CR-ABA院内感染192例,占74.42%,发生在ICU 116例,占全院的60.42%,下呼吸道CR-ABA感染147例,占感染的76.56%;2011-2012年社区感染率从0.67/千出院例数升高至1.20/千出院例数,而医院感染率从0.77/万住院日数降至0.71/万住院日数,社区感染显著升高而医院感染有所下降。结论 CR-ABA预防控制形势严峻,ICU为预防控制重点部门,下呼吸道感染为主要的预防控制感染部位,感染综合预防控制措施有效。 OBJECTIVE To understand the current status of epidemiology of carbapenems-resistant Acinetobacter baurnannii (CR-ABA) infections so as to prevent and control the CR-ABA infections. METHODS A prospective survey was carried out for the patients with Acinetobacter baumannii (ABA) infections from Jan. 1, 2011 to Dec 31, 2012. The types of the infections were determined, the characteristics of the CR-ABA infections were analyzed, the measures of the infection control were adopted, and the effects were observed. RESULTS of totally 258 case-times of ABA infections patients investigated, there were 192 (74.42 %) case-times of patients with CR- ABA infections, among which 116 (60. 42%) case-times of patients were from the ICU. There were 147 (76.56%) cases of patients with CR-ABA lower respiratory tract infections. The incidence of community-acquired infections was significantly higher in 2012 than that in 2011, increasing from 0. 67X0 to 1. 20%, however, the incidence of the nosocomial infections decreased from 0.77X0 to 0.71%, the incidence of the community-acquired infections was significantly increased, while the incidence of the nosocomial infections was decreased. CONCLUSION The situation of the control of CR-ABA infections is severe in the hospital. We should focus on ICUs, the lower respiratory tact is the predominant infection site; it is an effective way to take integrated control measures.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第7期1520-1522,共3页 Chinese Journal of Nosocomiology
关键词 耐碳青霉烯鲍氏不动杆菌 医院感染 社区感染 控制措施 Carbapenems-resistant Acinetobacter baumannii Nosocomial infection Community-acquired infec-tion Control measure
  • 相关文献

参考文献4

二级参考文献56

  • 1李耘,李家泰.ESBLs在大肠埃希菌、肺炎克雷伯菌和阴沟肠杆菌中的检出率及耐药情况比较[J].中国抗生素杂志,2005,30(3):151-158. 被引量:27
  • 2朱德妹,胡付品,汪复,蒋晓飞,俞云松,杨青,孙自镛,简翠,王传清,王爱敏,张泓,李万华,徐英春,孙宏莉,倪语星,孙景勇,徐元宏,沈继录,胡云建,艾效曼,单斌,杜艳,魏莲花,吴玲,苏丹虹,卓超,贾蓓,黄文祥,张朝霞,季萍.2009年中国CHINET葡萄球菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):414-420. 被引量:59
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3050
  • 4汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 5王贺,徐英春,陈民钧.细菌质粒介导的喹诺酮类抗菌药物耐药机制研究进展[J].中华医院感染学杂志,2007,17(5):618-620. 被引量:151
  • 6Goossens H,Ferech M,Vander Stichele R,et al.Outpatient antibiotic use in Europe and association with resistance:a cross-national database study[J].Lancet,2005,365(9459):579-587.
  • 7Hsueh PR,Chen WH,Luh KT.Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan[J].Int J Antimicrob Agents,2005,26(6):463 -472.
  • 8Rogues AM,Dumartin C,Amadéo B,et al.Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals[J].Infect Control Hosp Epidemiol,2007,28(12):1389-1395.
  • 9Perez F,Hujer AM,Hujer KM,et al.Global challenge of multidrug-resistant Acinetobacter baumannii[J].Antimicrob Agents Chemother,2007,51(10):3471-3484.
  • 10Falagas ME,Bliziotis IA,Siempos Ⅱ.Attributable mortality of Acinetobacter baumannii infections in critically ill patients:a systematic review of matched cohort and case-control studies[J].Crit Care,2006,10 (2):R48.

共引文献202

同被引文献28

  • 1盛美玲,周敏,王惠姣.呼吸内科下呼吸道感染主要革兰阴性菌分布及耐药性分析[J].中华临床感染病杂志,2011,4(6). 被引量:8
  • 2王秀贞,赵敏新.基层医院院内感染预防控制措施[J].中国公共卫生管理,2013,29(6):817-818. 被引量:4
  • 3袁小玲,高绍衍,夏秀琼,黄宇筠,区秀燕,缪炯矞.ICU洋葱伯克霍尔德菌医院下呼吸道感染危险因素及临床分析[J].中华医院感染学杂志,2006,16(12):1356-1358. 被引量:24
  • 4骆俊,沈继录,徐晓刚,胡付品,朱德妹,汪复.耐碳青霉烯类抗生素不动杆菌的β内酰胺酶研究[J].中国感染与化疗杂志,2007,7(2):79-83. 被引量:15
  • 5Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii : emergence of a successful pathogen[J]. Clin Microbiol Rev, 2008, 21(3) :538-582.
  • 6Zhou H,Yang Q,Yu YS,etal. Clo nal spread of imipenem re- sistant Acinetobacter baumannii among different cities of China [J]. J Clin Microbiol,2007,45(12) :4054-4057.
  • 7Lesho E, Wortmann G, Moran K, et al. Fatal Acinetobacter baumannii infection with discordant carbapenem susceptibility [J]. Clin Infect Dis,2005,41(5):758-759.
  • 8Lolans K, Rice T W, Munoz-Price LS, et al. Multieity out- break of carbapenem-resistant Acinetobacter baumannii iso- lates producing the carbapenemase OXA-40 [J]. Antimicrob Agents Chemother, 2006,50(9) : 2941-2945.
  • 9Seifert H, Stefanik D, Wisplinghoff H. Comparative in vitro activities of tigecycline and 11 other antimierobial agents a- gainst 215 epidemiologieally defined multidrug-resistant.Acin- etobacter baumannii isolates[J]. J Antimierob Chemother, 2006,58(5) :1099-1100.
  • 10Zhou QT,He B, Yao B, et al. lntra-hospital dissemination of carbapenem-resistant Acinetobacter baumannii and analysis of the infeeted patients prognosis[J]. Beijing Da Xue Xue Bao, 2011,43(2) :213 -221.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部